Skip to main content

Creative Planning

Position in NEO — Neogenomics Inc

CIK 1540235 OVERLAND PARK, KS

Position in NEO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$964,062
+$514,425 QoQ
Shares Held
66,077
+9.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 266 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Derivatives in NEO

reported options exposure · as of Dec 31, 2020
CallValue
$161,520
CallShares
3,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Creative Planning holds $272,210,544 across 30 Diagnostics & Research names. NEO ranks #22 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $964,062 66,077
2026-03-31 $449,637 60,598
2025-12-31 $634,640 53,966
2025-09-30 $339,208 43,939
2025-06-30 $122,332 16,735
2025-03-31 $131,863 13,895
2024-12-31 $367,916 22,325
2024-09-30 $347,318 23,547
2024-06-30 $229,451 16,543
2024-03-31 $277,473 17,651
2023-12-31 $273,506 16,904
2023-09-30 $1,254,747 102,012
2023-06-30 $1,621,977 100,932
2023-03-31 $1,767,080 101,498
2022-12-31 $937,906 101,505
2022-09-30 $561,690 65,237
2022-06-30 $199,503 24,479
2022-03-31 $142,786 11,752
2021-12-31 $408,552 11,974
2021-09-30 $661,515 13,713
2021-06-30 $908,593 20,115
2021-03-31 $561,590 11,644
2020-12-31 $161,520 3,000
2020-12-31 $453,117 8,416
2020-09-30 $269,333 7,301